Cure of recurring Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae septic shock episodes due to complicated soft tissue infection using a ceftazidime and avibactam-based regimen: a case report-Reference-Cited by-同舟云学术

Cure of recurring Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae septic shock episodes due to complicated soft tissue infection using a ceftazidime and avibactam-based regimen: a case report

Published:2019-01-22 Issue:1 Volume:13 Page:
ISSN:1752-1947
Container-title:Journal of Medical Case Reports
language:en
Short-container-title:J Med Case Reports

Author:

Parruti Giustino,Frattari Antonella,Polilli Ennio,Savini Vincenzo,Sciacca Antonina,Consorte Augusta,Cibelli Donatella Concetta,Agostinone Adriana,Di Masi Francesco,Pieri Alessandro,Cacciatore Pierluigi,Di Iorio Giancarlo,Fazii Paolo,Spina Tullio

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13256-018-1934-2.pdf

Reference10 articles.

1. Tumbarello M, Trecarichi EM, De Rosa FG, Giannella M, Giacobbe DR, Bassetti M, Losito AR, Bartoletti M, Del Bono V, Corcione S, Maiuro G, Tedeschi S, Celani L, Cardellino CS, Spanu T, Marchese A, Ambretti S, Cauda R, Viscoli C, Viale P, ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva). Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother. 2015;70(7):2133–43.

2. Conte V, Monaco M, Giani T, D’Ancona F, Moro ML, Arena F, D’Andrea MM, Rossolini GM, Pantosti A; AR-ISS Study Group on Carbapenemase-Producing K. pneumoniae. Molecular epidemiology of KPC-producing Klebsiella pneumoniae from invasive infections in Italy: increasing diversity with predominance of the ST512 clade II sublineage. J Antimicrob Chemother. 2016;71(12):3386–3391.

3. Caínzos M. Review of the guidelines for complicated skin and soft tissue infections and intra-abdominal infections--are they applicable today? Clin Microbiol Infect. 2008;14(Suppl 6):9–18.

4. Shields RK, Nguyen MH, Chen L, Press EG, Potoski BA, Marini RV, Doi Y, Kreiswirth BN, Clancy CJ. Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia. Antimicrob Agents Chemother. 2017;61(8):e00883–17. https://doi.org/10.1128/AAC.00883-17 .

5. Rafailidis PI, Falagas ME. Options for treating carbapenem-resistant Enterobacteriaceae. Curr Opin Infect Dis. 2014;27(6):479–83.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel evidence on sepsis-inducing pathogens: from laboratory to bedside;Frontiers in Microbiology;2023-06-23

2. Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients;Antibiotics;2022-07-26

3. Efficacy of Amikacin and Meropenem on Colistin-Induced Klebsiella pneumoniae Persisters;Microbial Drug Resistance;2022-07-01

4. Modelling of the transmission dynamics of carbapenem-resistant Klebsiella pneumoniae in hospitals and design of control strategies;Scientific Reports;2022-03-09

5. Ceftazidime-Avibactam for the Treatment of Serious Gram-Negative Infections with Limited Treatment Options: A Systematic Literature Review;Infectious Diseases and Therapy;2021-08-11